Sudarshan Pharma Industries share price
NSE: SUDARSHANBSE: 543828Chemicals & PetrochemicalsSmall Cap
Sudarshan Pharma Industries Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2023
Last close ₹37.92up ₹3.26 (9.41%)BSE ₹37.61
Share price at the NSE close on 28 Oct 2026. Previous close ₹34.66.
28 Oct: open ₹34.99, high ₹38.00, low ₹34.66
52-week range of BSE trades to 28 Oct 2026
₹18.50Low, 29 Jan 2026₹42.79High, 21 Jul 2026
- Next results date: the board meets on 29 Oct 2026 to consider: half yearly results, issue of warrants, financial results and fund raising. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹965 Cr1,697th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.81
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,67,16869.8% delivered
Results
Consolidated; ₹ crore.Sudarshan Pharma Industries quarterly results
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹174 Crdown 21.05%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹5.61 Crdown 50.76%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 3.2%
Revenue by quarter
Peak revenue ₹221 Cr, quarter to Mar 2026; lowest ₹145 Cr, quarter to Jun 2025
Net profit by quarter, a loss in red
| ₹ crore | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 145 | 169 | 168 | 221 | 174 |
| Net profit | 4 | 4 | 4 | 11 | 6 |
| Net margin | 2.7% | 2.3% | 2.5% | 5.2% | 3.2% |
Consolidated. The 5 quarters from Jun 2025, the first on record; the half years before them are below. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
| ₹ crore | Sep 2024 | Mar 2025 |
|---|---|---|
| Revenue | 228 | 277 |
| Net profit | 6 | 10 |
| Net margin | 2.6% | 3.6% |
Consolidated. The half years in the same span that the quarters on record do not fully cover.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹703 Crup 39.21%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹23 Crup 47.15%
- Net margin
- 3.3%
Revenue by year
Peak revenue ₹703 Cr, year to Mar 2026; lowest ₹461 Cr, year to Mar 2023
Net profit by year, a loss in red
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 461 | 464 | 505 | 703 |
| Net profit | 7 | 11 | 16 | 23 |
| Net margin | 1.5% | 2.5% | 3.1% | 3.3% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Chemicals And Solvents, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/B: the share count changed after the latest balance sheet (a rights issue, a buyback, an allotment or a listing), which does not yet hold the money it brought or returned.Sudarshan Pharma Industries PE ratio and valuation
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 73% of 738 trading days over the last 3 years.
LowestHighest
Its median0.00%Industry median0.53%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −20.6% | +47.0% | −46.0% | 0.0% |
| 3 years | +63.2% | +21.0% | +34.9% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Sudarshan Pharma Industries competitors and peers
Specialty Chemicals, 130 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Sudarshan Pharma Industries in market cap.Chemical companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Valiant OrganicsVALIANTORG | 1,279 | 23.65 | 1.68 | +1.4% | +963.3% | 7.3% | 6.4% | 0.00% |
 Platinum IndustriesPLATIND | 1,177 | 23.36 | 2.66 | +9.6% | +11.9% | 12.2% | 11.3% | 0.00% |
 Excel IndustriesEXCELINDUS | 1,118 | 15.67 | 0.66 | +5.5% | −18.9% | 4.3% | 4.3% | 1.55% |
 Jyoti Resins & AdhesivesJYOTIRES | 1,024 | 15.91 | 3.55 | +12.9% | −11.2% | 24.8% | 26.0% | 1.05% |
 Indo AminesINDOAMIN | 910 | 11.23 | 2.32 | +13.2% | +23.1% | 22.8% | 17.2% | 0.40% |
 Sunshield ChemicalsSUNSHIEL | 874 | 24.11 | 3.47 | +13.1% | +108.7% | 20.9% | 19.4% | 0.30% |
 SacheeromeSACHEEROME | 867 | 30.47 | 5.84 | – | – | 19.2% | – | 0.00% |
 Fairchem OrganicsFAIRCHEMOR | 853 | 35.88 | 3.03 | +17.4% | +292.5% | 8.3% | 10.4% | 0.15% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Sudarshan Pharma Industries dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹0.03 a share, year to Mar 2023.
| Ex-date | Type | Per share |
|---|---|---|
| 25 Aug 2023 | Final | ₹0.30 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Sudarshan Pharma Industries announcements
Oct 2026
23 Oct · Updates On Migration From SME Platform Of BSE To Capital Market Segment (Main Board) Of National Stock Exchange Of India Limited Of Sudarshan Pharma Industries Limited - Company Letter Bearing Ref. No. SPIL/CS/SE/2026-2027/20 Dated 21St May 2026
Sep 2026
Sudarshan Pharma Industries share price by year
Each calendar year to 2025.Sudarshan Pharma Industries share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025BSE close | 27.55 | −38.2% | 51.83 | 22.52 |
| 2024BSE close | 44.59 | +448.5% | 44.59 | 6.31 |
| 2023BSE close | 8.13 | – | 8.74 | 5.31 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 22 Mar 2023.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 33.82 | 35.00 | 32.10 | 34.66 | 34.42 | 87,439 | 61.7% |
| 26 Oct 2026 | 32.90 | 33.25 | 29.01 | 31.99 | 31.37 | 2,40,000 | – |
| 23 Oct 2026 | 32.57 | 33.00 | 31.20 | 31.25 | 31.85 | 40,000 | – |
| 22 Oct 2026 | 33.80 | 33.80 | 32.51 | 32.57 | 32.79 | 52,000 | – |
| 21 Oct 2026 | 35.20 | 35.20 | 33.61 | 33.80 | 34.32 | 64,000 | – |
| 19 Oct 2026 | 35.42 | 35.60 | 34.59 | 35.00 | 35.15 | 1,04,000 | – |
| 16 Oct 2026 | 35.20 | 36.99 | 35.06 | 36.40 | 36.29 | 72,000 | – |
| 15 Oct 2026 | 37.01 | 37.55 | 36.20 | 36.25 | 36.65 | 40,000 | – |
| 14 Oct 2026 | 37.99 | 37.99 | 36.51 | 36.74 | 37.16 | 72,000 | – |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 22 Nov 2024 | Split | 0.1000 | Each share became 10. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- NSE symbol
- SUDARSHAN
- BSE code
- 543828
- ISIN
- INE00TV01023
- Industry
- Chemicals & Petrochemicals
- Website
- www.sudarshanpharma.com
- CIN
- L51496MH2008PLC184997
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2008
- Registered office
- 301, Aura Biplex Above Kalyan Jewellers, 3rd Floor, S. V. Road, Mumbai 400092, Maharashtra
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments